(dihydro)ceramide synthase
Ceramide synthase 5 mediates lipid induced autophagy and hypertrophy in cardiomyocytes
13
Targeting ceramide synthase 6–dependent metastasis prone phenotype in lung cancer cells
13
Differential Regulation of Ceramide Synthase Components LAC1 and LAG1 in Saccharomyces cerevisiae
13
By activating Fas/ceramide synthase 6/p38 kinase in lipid rafts, Stichoposide D inhibits growth of leukemia xenografts
17
TAP independent self peptides enhance T cell recognition of immune escaped tumors
12
Ceramide/Long-Chain Base Phosphate Rheostat in Saccharomyces cerevisiae: Regulation of Ceramide Synthesis by Elo3p and Cka2p
11
Generation of specific deoxynojirimycin-type inhibitors of the non-lysosomal glucosylceramidase
7
The therapeutic potential of modulating the ceramide/sphingomyelin pathway
7
Daunorubicin activates NFkappaB and induces kappaB dependent gene expression in HL 60 promyelocytic and Jurkat T lymphoma cells
9
Obesity associated steatotic liver exhibits aberrant or altered sphingolipid composition and preferentially accumulates ceramide species containing long chain fatty acids
10
Ceramide activates NFkappaB by inducing the processing of p105
7
Trans-, cis-, and dihydro-resveratrol: a comparative study
6
Sphingolipid and ceramide homeostasis : potential therapeutic targets
12
Anti ceramide antibody prevents the radiation gastrointestinal syndrome in mice
6
Adiponectin/T-cadherin system enhances exosome biogenesis and decreases cellular ceramides by exosomal release
19
Expression of ceramide-metabolising enzymes in subcutaneous and intra-abdominal human adipose tissue
12
Cytotoxic and inhibitory activity of ceramide on cancer cell lines
8
Anti Plasmodium activity of ceramide analogs
10
The antiproliferative effect of C2-ceramide on lung cancer cells through apoptosis by inhibiting Akt and NFκB
7
Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3' sulfo-galactosyl ceramide-positive cell line.
8